Early-onset preeclampsia was associated with increased risk for delayed early-childhood development in the domain of ...
The U.S. Food and Drug Administration has declined to approve Corcept Therapeutics' drug for the treatment of a rare hormonal ...
Corcept Therapeutics Inc. shares fell after US regulators rejected the company’s drug to treat a form of high blood pressure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback